Publications by authors named "Xi Ming Tang"

12Publications

A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma.

Oncologist 2020 Oct 19;25(10):e1457-e1463. Epub 2020 Jul 19.

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
October 2020

Germline Mutation of T790M and Dual/Multiple EGFR Mutations in Patients With Lung Adenocarcinoma.

Clin Lung Cancer 2016 Mar 17;17(2):e5-11. Epub 2015 Nov 17.

Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
March 2016

MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression.

Am J Pathol 2012 May 10;180(5):1772-80. Epub 2012 Mar 10.

Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
May 2012

Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.

J Clin Oncol 2010 Oct 20;28(30):4609-15. Epub 2010 Sep 20.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article and Find Full Text PDF
October 2010

Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.

J Thorac Oncol 2006 Mar;1(3):231-9

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article and Find Full Text PDF
March 2006

Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells.

Clin Cancer Res 2004 Dec;10(24):8284-92

Divisions of Oncology, Gastroenterology and Hepatology, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA. sinicrope.frank2mayo.edu

View Article and Find Full Text PDF
December 2004

Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.

Cancer Res 2002 Nov;62(21):6323-8

Department of Gastrointestinal Medicine and Nutrition, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

View Article and Find Full Text PDF
November 2002

Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.

Cancer Res 2002 Mar;62(6):1676-81

Department of Gastrointestinal Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
March 2002